How to tell if your pain is from Fibro – and how to talk to you doctor about it.

Are you or a loved one living with unexplained pain? In this enlightening episode, Dr. Elizabeth Ortiz breaks down the science behind Nociplastic pain and offers valuable insights to start the Fibro conversation with your doctor! Video Key Takeaways Fibromyalgia is a clinical syndrome characterized by widespread musculoskeletal pain, along with associated symptoms like fatigue, sleep disturbances, mood disorders, and brain fog. Fibromyalgia is a real condition with genuine pain.

The pain of fibromyalgia is termed “Nociplastic pain,” which results from a dysregulated nervous system, leading to hypersensitivity to pain signals. Fibromyalgia pain can manifest as deep, aching pain that is not logically connected to a specific injury, and it can occur on both sides of the body and above and below the waist. It’s essential to discuss the possibility of fibromyalgia with a doctor, explore medication options, and consider lifestyle changes such as diet, sleep, movement, and community support to manage fibromyalgia pain effectively.

Frequently need to pee? App-based therapy can help, finds research.

Combining pelvic floor exercises with behavioural therapy could be more effective than current medical treatments at helping men with frequent urges to urinate, new research in men has found.

The results reveal that an app-based therapy significantly improves the lower urinary tract symptoms that many millions of men experience—hesitancy, straining, frequent urges to urinate, and effective bladder emptying. The full trial results are expected to be published later this year.

This could be useful to people with multiple sclerosis, diabetes, rheumatoid arthritis, and other conditions, as well as to the general population.

Carried out in Germany, this is the world’s first randomised controlled trial to look at combining pelvic floor training, behavioural therapy and bladder control techniques for mild, moderate and severe bladder emptying disorders in men, all delivered as an app-based therapeutic.

Bladder emptying disorders can start to appear from the age of 30 and typically affect a large proportion of men aged over 50.

While clinical guidelines recommend physiotherapy, behavioural therapy and lifestyle changes as a first-line treatment, clinicians often neglect them due to a lack of available evidence. Several unpleasant side effects are associated with the few drugs available, and surgery is only advised for those with severe symptoms.

Professor Christian Gratzke, from University Hospital Freiburg in Germany, who co-led the trial, explains: “Frequent urges to urinate and issues emptying the bladder are the most prevalent urinary conditions we see in men after urinary tract infections. While some drugs are available, they don’t tend to be effective, and up until now, there’s been little data available to back physiotherapy. We’re confident that we now have that data, and making this form of therapy available digitally could be a game changer for the millions of men who struggle day-to-day with issues emptying their bladder.”

The researchers recruited 237 men aged 18 across Germany into their 12-week study. Half the men were randomised to receive standard medical care, while the other half were given access to the Kranus Lutera app-based therapy alongside standard care. These participants were asked to record a urination diary, which was used to inform their treatment, and complete questionnaires about their symptoms’ severity and overall quality of life.

After 12 weeks, the trial found significant and clinically meaningful improvements in symptoms and quality of life measures from participants given the app-based therapy, who reported an average seven-point increase in symptom scores compared to those in the control group.

The study found that app-based therapy was more effective than medical therapy. No patients reported any side effects or challenges accessing the smartphone app.

The findings challenge the dogma of the 1980s and 1990s, when prostrate surgery was the first line of treatment for an overactive bladder, and offer a welcome alternative to drugs, say the researchers.

“Many men with bladder emptying disorders are ageing and have other medical conditions that require drug treatments,” says Professor Gratzke. “The limited drugs we have available aren’t suitable for these patients due to their side effects. For those with mild-to-moderate urinary symptoms, this digital therapy is without side effects and improves symptoms by a magnitude we have not seen before. Simply strengthening the pelvic floor makes all the difference, it’s a no brainer.”

Jean-Nicolas Cornu, Professor of Urology at the Charles Nicolle Hospital in France and member of the EAU Scientific Congress Office, said: “There has been little to no evidence to support training men to better control their bladders, despite this being recommended in clinical guidelines. This is the first randomised controlled trial looking at physiotherapy and behavioural therapy for bladder emptying disorders, and it shows a very positive effect over conventional drug treatment.

“We now need a bigger trial looking at the longer-term effect of this app-based therapy after 12 weeks for different forms of bladder emptying disorders. If offered widely, this treatment could dramatically change clinical practice, and could relieve symptoms without exposing patients to drugs. We could save a lot of unnecessary prescriptions for drugs that tend to be of little benefit.”

The researchers compared data from men whose symptoms were due to overactive bladder with those whose symptoms were due to an enlarged prostate. They found that both groups benefited from the therapy. However, it did not compare the effect of therapy on different forms of bladder emptying disorder.

How to deal with autoimmune disease flares- A Rheumatologist POV

Flares happen. We do everything we can to prevent them and understand why they occur, but sometimes, they just happen. This is true regardless of the inflammatory or autoimmune disease: lupus, arthritis, fibromyalgia, vasculitis, and all the others. As frustrating as they can be, there are things you can do to manage them with care and grace.

A blood test will diagnose fibromyalgia more reliably

#

medical visit

#

CREDIT Mart Production (Pexels).

A research team from the Universitat Rovira i Virgili, the University of Ohio and the University of Texas has developed an innovative method for reliably diagnosing fibromyalgia from a blood sample. Identifying this disease nowadays is highly complex, especially because the symptoms are similar to those of other rheumatic pathologies and persistent COVID-19. This new study represents an important step forward in the accurate diagnosis and personalisation of treatment for affected individuals, and at the same time, opens new avenues for research into this pathology and clinical care. The results of the study have been published in the journal Biomedicines.

#

Fibromyalgia is a chronic disease that affects 6% of the population worldwide and is characterized by widespread muscle pain and fatigue. The variety of symptoms can easily be confused with other disorders, such as rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis or chronic low back pain. This means that reaching a diagnosis is not easy or quick and, therefore, ends up having an impact on the quality of life and mental health of the people who suffer from it.

#

To carry out the study, the research team collected blood samples from three different groups: people diagnosed with fibromyalgia, people with similar rheumatic diseases and people without any of these pathologies, who served as a control group. A combination of techniques was used to isolate and analyse specific chemical signals in the blood that could help differentiate fibromyalgia from other diseases with similar effects on health to open a more accurate and faster diagnostic pathway.

The blood samples underwent filtration, which allows the focus to be put on a very specific part of the blood that contains small molecules, known as the low molecular weight fraction. These molecules can include a variety of substances, for example, amino acids, which act as the building blocks of proteins.

To analyse these tiny molecules, the researchers used the technique of Raman spectroscopy, which consists of “illuminating” the samples with a special laser light and studying how they react. This technique makes it possible to observe which molecules are present and in what quantities based on how light interacts with them. Gold nanoparticles were used to refine this process further, increasing the signal they receive from the small molecules and making the results clearer and easier to interpret.

A statistical method classified the samples based on their chemical characteristics so that the differences between groups could be determined. The results highlighted that some patterns in small molecules, such as amino acids, could serve as “chemical signatures” to distinguish fibromyalgia from other diseases.

“This tool is fast, accurate and non-invasive, and can easily be integrated into the clinical environment to improve the quality of life of patients with fibromyalgia”, says Sílvia de Lamo, a researcher from the URV’s Chemical Engineering Department, who played a part in the research during a stay at Ohio University, where she collaborates with two research groups specialising in vibrational spectroscopy as a method for diagnosing diseases. The tool, which is still in the validation phase, could be available in health centres in about two years, according to the research team.

Two types of CBT are equally effective in the treatment of fibromyalgia.

Maria Hedman-Lagerlöf

Maria Hedman-Lagerlöf CREDIT Andreas Beronius

There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in treating fibromyalgia, according to a study led by researchers at Karolinska Institutet. Both forms of treatment produced a significant reduction in symptoms in people affected by the disease. The study is one of the largest to date to compare different treatment options for fibromyalgia and is published in the journal PAIN.



About 200,000 people in Sweden currently live with fibromyalgia, a long-term pain syndrome that causes great suffering for patients through widespread pain, fatigue, and stiffness in the body. There is no cure for fibromyalgia. Existing drugs often have insufficient effect, raising the need for more effective treatment methods. Cognitive behavioural therapy (CBT) has shown some effect, but there is a lack of trained CBT practitioners. There is also a lack of knowledge about which
CBT is most effective. 


The study compared two different forms of internet-delivered cognitive behavioural therapy in terms of how well they reduce the symptoms and functional impact of fibromyalgia. 

In brief, exposure-based CBT involves the participant systematically and repeatedly approaching situations, activities, and stimuli that the patient has previously avoided because the experiences are associated with pain, psychological discomfort, or symptoms such as fatigue and cognitive problems. 

In traditional CBT, the participant is presented with several strategies to work on during treatment, such as relaxation, activity planning, physical exercise, or strategies for managing negative thoughts and improving sleep. 

The study showed that traditional CBT was, by and large, equivalent to the newer treatment form of exposure-based CBT. 

“This result was surprising because our hypothesis, based on previous research, was that the new exposure-based form would be more effective. Our study shows that the traditional form can provide an equally good result and thus contributes to the discussion in the field,” says Maria Hedman-Lagerlöf, licensed psychologist and researcher at the Center for Psychiatry Research at the Department of Clinical Neuroscience, Karolinska Institutet.

The randomized study involved 274 people with fibromyalgia, who were randomly assigned to be treated with traditional or exposure-based CBT. The treatments were delivered entirely online, and all participants had regular contact with their therapist. 

Participants answered questions about their mood and symptoms before, during, and after treatment. After the 10-week treatment, 60 per cent of those who received exposure-based CBT and 59 per cent of those who received traditional CBT reported that their treatment had helped them.

“The fact that both treatments were associated with a significant reduction in the participants’ symptoms and functional impairment and that the effects were sustained for 12 months after completion of the treatment, indicates that the internet as a treatment format can be of great clinical benefit for people with fibromyalgia,” says Maria Hedman-Lagerlöf. “This is good news because it enables more people to access treatment.” 

The study is the second largest to compare different psychological treatment options for fibromyalgia, according to the researchers.

“Our study is also one of the first to compare with another active, established psychological treatment,” says Maria Hedman-Lagerlöf.